---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-000921"
form_type: "8-K"
ticker: "ITGR"
cik: "0001114483"
company_name: "Integer Holdings Corp"
filed_at: "2026-02-19T23:59:59+00:00"
generated_at: "2026-05-16T01:39:15.284311+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Integer reports Q4 adjusted EPS $1.76, 23% YoY growth; full year adjusted EPS $6.40, up 21%

## Summary
- Q4 sales $472M (+5% YoY); GAAP EPS $1.38, adjusted EPS $1.76 (+23%).
- FY25 sales $1.854B (+8%); GAAP EPS $2.89 (-15%), adjusted EPS $6.40 (+21%).
- Cardio & Vascular sales grew 11% Q4; Cardiac Rhythm Mgmt & Neuromodulation down 2% Q4.
- Initiates $50M accelerated share repurchase under existing $200M board authorization.
- 2026 outlook: sales $1.826B-$1.876B (flat YoY); adjusted EPS $6.29-$6.78 (down 2% to up 6%).

## SEC filing metadata
- accession: 0001171843-26-000921
- form_type: 8-K
- ticker: ITGR
- cik: 0001114483
- company_name: Integer Holdings Corp
- filed_at: 2026-02-19T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1114483/000117184326000921/0001171843-26-000921-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1114483/000117184326000921/f8k_021926.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-000921
- JSON: https://secwatch.observer/filing/0001171843-26-000921.json
- Plain text: https://secwatch.observer/filing/0001171843-26-000921.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.